| Name | Title | Contact Details |
|---|---|---|
Kory Anderson |
Vice President, Information Security | Profile |
Kory Anderson |
Vice President, Information Security | Profile |
Richard Weiss |
Director, Information Security | Profile |
Jason Cooper |
Senior Vice President and Chief Analytics Officer | Profile |
Sanjeev Kumar |
Vice President of Data Engineering and Analytics and Chief Technology office | Profile |
Based in New York City, Kaden is a behavioral health company dedicated to solving the greatest healthcare challenges of our time with ground-breaking technology and unwavering humanity. Kaden`s first product tackles the opioid addiction crisis by positively influencing human behavior and making advanced technologies and proven treatments accessible to all so that no one has to fight opioid or any addiction alone.
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
Fitness classes, lap pool, personal training, weight-loss programs, Pilates, weight training and more. Free mini-membership. All ages and fitness levels welcome.
The Pill Club is the first all-in-one healthcare startup delivering and prescribing birth control across the US.
DeRoyal manufactures quality healthcare products worldwide. DeRoyal is behind everything from the number one orthopedic hospital brand to online tools that power the medical industry. We keep innovating because it's part of our heritage.